Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 9 studies | 26% ± 10% | |
glutamatergic neuron | 5 studies | 17% ± 2% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 6% |
Insufficient scRNA-seq data for expression of POU3F2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1322.75 | 2623 / 2642 | 99% | 53.76 | 700 / 705 |
skin | 0% | 0.07 | 1 / 1809 | 60% | 6.35 | 284 / 472 |
adrenal gland | 0% | 0 | 0 / 258 | 17% | 1.02 | 39 / 230 |
lung | 0% | 0 | 0 / 578 | 10% | 1.97 | 115 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.47 | 3 / 45 |
esophagus | 0% | 0.68 | 5 / 1445 | 5% | 0.47 | 10 / 183 |
uterus | 0% | 0 | 0 / 170 | 5% | 0.88 | 21 / 459 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.64 | 11 / 504 |
liver | 0% | 0 | 0 / 226 | 2% | 0.08 | 8 / 406 |
stomach | 0% | 0 | 0 / 359 | 2% | 0.13 | 5 / 286 |
breast | 0% | 0.38 | 1 / 459 | 1% | 0.58 | 16 / 1118 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.13 | 4 / 430 |
adipose | 1% | 1.27 | 9 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.34 | 1 / 178 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.02 | 2 / 527 |
blood vessel | 0% | 0.62 | 5 / 1335 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.02 | 2 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021869 | Biological process | forebrain ventricular zone progenitor cell division |
GO_0008544 | Biological process | epidermis development |
GO_0021897 | Biological process | forebrain astrocyte development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0048663 | Biological process | neuron fate commitment |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0048665 | Biological process | neuron fate specification |
GO_0021979 | Biological process | hypothalamus cell differentiation |
GO_0022011 | Biological process | myelination in peripheral nervous system |
GO_0030182 | Biological process | neuron differentiation |
GO_0061101 | Biological process | neuroendocrine cell differentiation |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_0048666 | Biological process | neuron development |
GO_0050770 | Biological process | regulation of axonogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0007399 | Biological process | nervous system development |
GO_0040018 | Biological process | positive regulation of multicellular organism growth |
GO_0021799 | Biological process | cerebral cortex radially oriented cell migration |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0021985 | Biological process | neurohypophysis development |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | POU3F2 |
Protein name | POU domain, class 3, transcription factor 2 (Brain-specific homeobox/POU domain protein 2) (Brain-2) (Brn-2) (Nervous system-specific octamer-binding transcription factor N-Oct-3) (Octamer-binding protein 7) (Oct-7) (Octamer-binding transcription factor 7) (OTF-7) |
Synonyms | OTF7 BRN2 OCT7 |
Description | FUNCTION: Transcription factor that plays a key role in neuronal differentiation (By similarity). Binds preferentially to the recognition sequence which consists of two distinct half-sites, ('GCAT') and ('TAAT'), separated by a non-conserved spacer region of 0, 2, or 3 nucleotides (By similarity). Acts as a transcriptional activator when binding cooperatively with SOX4, SOX11, or SOX12 to gene promoters (By similarity). The combination of three transcription factors, ASCL1, POU3F2/BRN2 and MYT1L, is sufficient to reprogram fibroblasts and other somatic cells into induced neuronal (iN) cells in vitro (By similarity). Acts downstream of ASCL1, accessing chromatin that has been opened by ASCL1, and promotes transcription of neuronal genes (By similarity). . |
Accessions | P20265 ENST00000328345.8 [P20265-1] |